ChemFeeds Site Navigation:
Journal Selection:
Search:

99) The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy (Clinical Cancer Research) Monday December 14th 2015


100) Pharmacologic Effects of RET ADCs (Clinical Cancer Research) Monday December 14th 2015


101) Oncolytic Virus Combination with Checkpoint Inhibitors (Clinical Cancer Research) Monday December 14th 2015


102) Overcoming CKS1B-Induced Drug Resistance with MLN4924 (Clinical Cancer Research) Monday December 14th 2015


103) HER3-EGFR Blockade in HER2-Amplified Gastrointestinal Cancer (Clinical Cancer Research) Monday December 14th 2015


104) FDG Dose Painting and Tumor Response (Clinical Cancer Research) Monday December 14th 2015


105) Mutant TP53 Limits Efficacy of MEK plus PI3K/mTOR in Colorectal Cancer (Clinical Cancer Research) Monday December 14th 2015


106) Chemotherapy Blocks the Invasive Effects of Antiangiogenics (Clinical Cancer Research) Monday December 14th 2015


107) Prospectively Validated Scoring System in Cervical Cancer (Clinical Cancer Research) Monday December 14th 2015


108) Panitumumab plus FOLFIRI and RAS Mutations in Colorectal Cancer (Clinical Cancer Research) Monday December 14th 2015


109) Predicting the Response in Triple-Negative Breast Cancer (Clinical Cancer Research) Monday December 14th 2015


110) Predictive Markers for Melanoma Treatment with Ipilimumab (Clinical Cancer Research) Monday December 14th 2015


111) Motolimod Activation of TLR8 in Late-Stage Cancer Patients (Clinical Cancer Research) Monday December 14th 2015


112) ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer (Clinical Cancer Research) Monday December 14th 2015


113) FASN (Clinical Cancer Research) Monday December 14th 2015


114) Molecular Pathways of IDO in Tumor Immunotherapy (Clinical Cancer Research) Monday December 14th 2015


115) Lenvatinib for Differentiated Thyroid Cancer (Clinical Cancer Research) Monday December 14th 2015


116) Enhancing Oncolytic Viral Therapy against Cancer (Clinical Cancer Research) Monday December 14th 2015


117) RAS Mutations and Colorectal Cancer Therapy (Clinical Cancer Research) Monday December 14th 2015


118) MAPK/ERK Inhibition in Melanoma: Kinase Inhibition Redux (Clinical Cancer Research) Monday December 14th 2015


119) Cell Transfer Immunotherapy for Human Cancer (Clinical Cancer Research) Monday December 14th 2015


120) Missed Opportunities and Lost Lives: Consequences of Some Proposed Changes to Regulations on Research with Human Tissues--Letter (Clinical Cancer Research) Tuesday December 1st 2015


121) E2F1-EZH2-SUZ12 Prognosis Marker in Bladder Cancer (Clinical Cancer Research) Tuesday December 1st 2015


122) Antibody Cleavage in the Tumor Microenvironment (Clinical Cancer Research) Tuesday December 1st 2015


123) Transcriptomic Profiles of Metastatic Breast Cancer (Clinical Cancer Research) Tuesday December 1st 2015


124) Activation of PIK3CA in Latin American Cervical Cancer (Clinical Cancer Research) Tuesday December 1st 2015


125) Aspirin Suppresses Osteosarcoma through the NF-{kappa}B Pathway (Clinical Cancer Research) Tuesday December 1st 2015


126) Apo2L/TRAIL Induces Apoptosis in Senescent Tumor Cells (Clinical Cancer Research) Tuesday December 1st 2015


127) Pyrvinium Targets CD133 in Human Glioblastoma (Clinical Cancer Research) Tuesday December 1st 2015


128) F14512 Dose-Escalation Trial in Spontaneous Canine Lymphoma (Clinical Cancer Research) Tuesday December 1st 2015


129) EGFR Exon 18 Mutations in Lung Cancer (Clinical Cancer Research) Tuesday December 1st 2015


130) Prognosis of BRAF and KRAS Mutations by Colon Cancer Site (Clinical Cancer Research) Tuesday December 1st 2015


131) Stool Profiling in mRCC (Clinical Cancer Research) Tuesday December 1st 2015


132) 89Zr-J591 ImmunoPET in Metastatic Prostate Cancer (Clinical Cancer Research) Tuesday December 1st 2015


133) Genome-wide Analysis of Ovarian Cancer Outcomes (Clinical Cancer Research) Tuesday December 1st 2015


134) Gene Signatures Predictive of Response to Therapy in NSCLC (Clinical Cancer Research) Tuesday December 1st 2015


135) S-1 versus Cisplatin+S-1 in Completely Resected NSCLC (Clinical Cancer Research) Tuesday December 1st 2015


136) Phase I Trial of Ridaforolimus plus MK-2206 in Advanced Cancer (Clinical Cancer Research) Tuesday December 1st 2015


137) Clinical Response of CML to MEK Inhibition (Clinical Cancer Research) Tuesday December 1st 2015


138) BRAF Inhibitors and GI Polyps (Clinical Cancer Research) Tuesday December 1st 2015


139) Targeting Cytoskeletal Balance in Cancer (Clinical Cancer Research) Tuesday December 1st 2015


140) FDA Approval of Lenvatinib for Thyroid Cancer (Clinical Cancer Research) Tuesday December 1st 2015


141) New Strategies: SABR for Oligometastases (Clinical Cancer Research) Tuesday December 1st 2015


142) New Strategies in Engineering TCR Gene-Modified T cells (Clinical Cancer Research) Tuesday December 1st 2015


143) Predictive Markers for VEGF and EGFR Inhibition in NSCLC (Clinical Cancer Research) Tuesday December 1st 2015


144) ALK Fusion Clinicopathologic Features (Clinical Cancer Research) Tuesday December 1st 2015


145) Correction: Aurora A Inhibitor (MLN8237) plus Vincristine plus Rituximab Is Synthetic Lethal and a Potential Curative Therapy in Aggressive B-cell Non-Hodgkin Lymphoma (Clinical Cancer Research) Friday November 13th 2015


146) TERT Polymorphism and EGFR Mutations in NSCLC (Clinical Cancer Research) Friday November 13th 2015


147) Cellular Senescence Markers in Hodgkin Lymphoma (Clinical Cancer Research) Friday November 13th 2015


148) Biomarkers of Response for Epigenetic Drug Evaluation (Clinical Cancer Research) Friday November 13th 2015


149) Preclinical Development of NaPi2b Antibody-Drug Con{#x0237}ugate (Clinical Cancer Research) Friday November 13th 2015


150) Enhanced Tumor Targeting of SN-38 with Sacituzumab Govitecan (Clinical Cancer Research) Friday November 13th 2015


151) SERM- or SERD-CDK4/6 Inhibitor Combination in Breast Cancer (Clinical Cancer Research) Friday November 13th 2015


152) EGFR-Dependent Modulation of OXPHOS in NSCLC (Clinical Cancer Research) Friday November 13th 2015


153) CDK2 Inhibitor AT7519 for MYCN-Dependent Neuroblastoma (Clinical Cancer Research) Friday November 13th 2015


154) CTx and sVEGFR2 in Combination Sunitinib/Cilengitide Study (Clinical Cancer Research) Friday November 13th 2015


155) GWAS for Taxane-Induced Peripheral Neuropathy (Clinical Cancer Research) Friday November 13th 2015


156) Hyperpolarized 13C-MRI Detects Response to Radiotherapy (Clinical Cancer Research) Friday November 13th 2015


157) Racemic Distribution and Peritoneal Bioactivity of Ketorolac (Clinical Cancer Research) Friday November 13th 2015


158) Impact of Consensus Phase II Recommendations (Clinical Cancer Research) Friday November 13th 2015


159) Cytotoxic Lymphocytes, Cell Death, and Cancer Immunotherapy (Clinical Cancer Research) Friday November 13th 2015


160) Autophagy, Metabolism, and Cancer (Clinical Cancer Research) Friday November 13th 2015


161) Smac Mimetics as Cancer Therapeutics (Clinical Cancer Research) Friday November 13th 2015


162) BCL-2 Antagonism to Target Apoptosis (Clinical Cancer Research) Friday November 13th 2015


163) Cell Death and Cancer Therapy (Clinical Cancer Research) Friday November 13th 2015


164) How Do Cancer Cells Die? (Clinical Cancer Research) Friday November 13th 2015


165) Targeting DGK{alpha} in Cancer (Clinical Cancer Research) Friday November 13th 2015


166) Hippo as a Tumor Suppressor (Clinical Cancer Research) Friday November 13th 2015


167) {#x201C}Braking{#x201D} the Cycle of Endocrine Resistance (Clinical Cancer Research) Friday November 13th 2015


168) Metabolic Imaging Biomarker of Early Radiation Response (Clinical Cancer Research) Friday November 13th 2015


169) Circulating Tumor Cells in Prostate Cancer (Clinical Cancer Research) Friday November 13th 2015


170) Capturing Clinical Activity in Immuno-Oncology (Clinical Cancer Research) Friday November 13th 2015


171) AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--Letter (Clinical Cancer Research) Sunday November 1st 2015


172) miRNA-mRNA Pairs Drive Prostate Cancer Disparities (Clinical Cancer Research) Sunday November 1st 2015


173) Creation of a Human Secretome (Clinical Cancer Research) Sunday November 1st 2015


174) CDK4/6 Inhibition in Fusion-Positive RMS (Clinical Cancer Research) Sunday November 1st 2015


175) Cooperating Events in Ewing Sarcoma (Clinical Cancer Research) Sunday November 1st 2015


176) Tumor Suppressive Role of miR-195 in Prostate Cancer (Clinical Cancer Research) Sunday November 1st 2015


177) Subclonal ALK Mutations in Neuroblastoma at Diagnosis (Clinical Cancer Research) Sunday November 1st 2015


178) Primary Melanoma miRNA Signature Predicts Brain Metastasis (Clinical Cancer Research) Sunday November 1st 2015


179) LOXL2 in Colon Cancer Prognosis (Clinical Cancer Research) Sunday November 1st 2015


180) The Tumor Suppressor Roles of miRNA-374b in T-LBL (Clinical Cancer Research) Sunday November 1st 2015


181) SFRP3 in aRMS Tumorigenesis (Clinical Cancer Research) Sunday November 1st 2015


182) Nintedanib Therapy for PNET (Clinical Cancer Research) Sunday November 1st 2015


183) Lipid Nanoparticle siRNA Systems in CRPC (Clinical Cancer Research) Sunday November 1st 2015


184) AZD-1775 Sensitizes HPV+ HNSCC to Cisplatin Therapy (Clinical Cancer Research) Sunday November 1st 2015


185) Targeting Soluble MIC for Cancer Immunotherapy (Clinical Cancer Research) Sunday November 1st 2015


186) SPARC Results for nab-Paclitaxel + Gemcitabine in the MPACT Study (Clinical Cancer Research) Sunday November 1st 2015


187) Lenvatinib Phase I Safety, PK/PD, and Mutational Profiles (Clinical Cancer Research) Sunday November 1st 2015


188) CTCs and ctDNA: Path to Clinical Utility (Clinical Cancer Research) Sunday November 1st 2015


189) Targeting ATR in Cancer Therapy (Clinical Cancer Research) Sunday November 1st 2015


190) Targeting the STING Pathway in the Immunotherapy of Cancer (Clinical Cancer Research) Sunday November 1st 2015


191) Panobinostat for Treatment of Multiple Myeloma (Clinical Cancer Research) Sunday November 1st 2015


192) FDA Approval Summary for Palbociclib for ER+, HER2- MBC (Clinical Cancer Research) Sunday November 1st 2015


193) New Strategies in Sarcoma (Clinical Cancer Research) Sunday November 1st 2015


194) Gene Dose and Drug Sensitivity (Clinical Cancer Research) Sunday November 1st 2015


195) Subclonal ALK Mutations (Clinical Cancer Research) Sunday November 1st 2015


196) Deciphering Gene-Expression Signatures in Breast Cancer (Clinical Cancer Research) Sunday November 1st 2015


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()